Effects of vitamin D supplementation and seasonality on circulating cytokines in adolescents: analysis of data from a feasibility trial in Mongolia

Sergey Yegorov; Sabri Bromage; Ninjin Boldbaatar; Davaasambuu Ganmaa

doi:10.1101/19001842

ABSTRACT

Vitamin D deficiency is prevalent in human populations and has been linked to immune dysfunction. Here we explored the effects of cholecalciferol supplementation on circulating cytokines in severely vitamin D deficient (blood 25(OH)D₃ << 30 nmol/L) adolescents aged 12-15 from Mongolia. The study included 28 children receiving 800 IU daily cholecalciferol for 6 months spanning winter and spring, and 30 children receiving placebo during the same period. The levels of 25(OH)D₃ were assessed at baseline, three and six months. Twenty-one cytokines were measured in serum at baseline and at six months. The median blood 25(OH)D₃ concentration at baseline was 13.7 nmol/L (IQR=10.0-21.7). Supplementation tripled blood 25(OH)D₃ levels (p<0.001) and reversed the direction of change for most cytokines (16/21, 86%). Supplementation was associated with elevated interleukin (IL)-6 (p=0.043). The placebo group had reduced MIP-1α (p=0.007) and IL-8 (p=0.034) at six months. These findings suggest that cholecalciferol supplementation and seasonality have a measurable impact on circulating cytokines in adolescents, identifying chemokines as potentially important biomarkers of vitamin D status in this population.

ClinicalTrial.org ID: NCT01244204

Competing Interest Statement

The authors have declared no competing interest.

Clinical Trial

NCT01244204

Funding Statement

This study was supported by the NIH/NHLBI 1K99HL089710-01A1 grant to GD. We acknowledge the support of Harvard Catalyst - Laboratory for Innovative Translational Technologies (HC-LITT) at Harvard Institutes of Medicine with cytokine assays.

Author Declarations

All relevant ethical guidelines have been followed and any necessary IRB and/or ethics committee approvals have been obtained.

Yes

All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.

Yes

Any clinical trials involved have been registered with an ICMJE-approved registry such as ClinicalTrials.gov and the trial ID is included in the manuscript.

Yes

I have followed all appropriate research reporting guidelines and uploaded the relevant Equator, ICMJE or other checklist(s) as supplementary files, if applicable.

Yes

Footnotes

Author emails: sergey.yegorov{at}sdu.edu.kz (SY), sbromage{at}mail.harvard.edu (SB), nboldbaa{at}gmail.com(NB), gdavaasa{at}hsph.harvard.edu(GD).

Data Availability

All data generated or analyzed during this study are included in this published article.

The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC-ND 4.0 International license.